Neonatal Screening

Newborn Screening is a program that identifies babies at risk of having rare, but serious medical conditions that can affect normal development. Baby Shield Newborn Screening combines biochemical testing of 100+ metabolic & genetic conditions with confirmatory genetic testing for screen-positive results.It aims to achieve early identification of conditions. Thus, resulting in early intervention that can lead to the elimination or reduction of mortality, morbidity and disability in affected newborns.


    Related Conference of Neonatal Screening

    March 28-29, 2024

    23rd Annual World Congress on Neonatology

    Dubai, UAE
    May 23-24, 2024

    37th World Pediatrics Conference

    Zurich, Switzerland
    May 27-28, 2024

    36th European Pediatrics Congress

    Amsterdam, Netherlands
    June 13-14, 2024

    3rd World Pediatric Conference

    Rome, Italy
    June 13-14, 2024

    22nd World Congress on Clinical Pediatrics

    Rome, Italy
    June 13-14, 2024

    32nd World Congress on Clinical Pediatrics

    Rome, Italy
    June 19-20, 2024

    9th Annual Summit on Pediatric Cardiology

    Rome, Italy
    July 18-19, 2024

    35th European Pediatrics Conference

    Paris, France
    August 19-20, 2024

    25th Annual World Congress on Pediatrics

    Zurich, Switzerland
    September 05-06, 2024

    24th World Congress on Pediatric Neurology and Neuropathology

    Brussels, Belgium
    September 16-17, 2024

    7th World Pediatric Infectious Disease Congress

    Zurich, Switzerland
    September 19-20, 2024

    25th World Congress on Pediatric Oncology and Cancer Care

    Paris, France
    September 19-20, 2024

    3rd International Conference on Neonatology

    Paris, France

    Neonatal Screening Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in